FORM OF SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • November 9th, 2020 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
This Separation and Release Agreement (the “Agreement”), dated as of [●], is entered into between Myriad Genetics, Inc. (together with its subsidiaries, affiliates, successors and assigns, the “Company”), and [●] (“Executive”) (Executive, together with the Company, the “Parties” and each a “Party”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2020 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
This Executive Employment Agreement (the “Agreement”), made and entered into this 24 day of July, 2020 (the “Effective Date”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and Paul J. Diaz (“Executive”).
